MENLO PARK, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced Jim Gibson will join and be appointed as the company’s new Chief Financial Officer, effective as of his start date, which is expected to be March 31, 2025. With over three decades of…
Fri, 09 May 2025 04:24:00 GMT Good afternoon and welcome to PacBio's first-quarter 2025 earnings conference call. Earlier today, we issued a press release outlining ... and Jim Gibson, Chief Financial Officer.
Thu, 08 May 2025 13:35:00 GMT GAAP net loss for the first quarter of 2025 was $426.1 million, compared to $78.2 million for the first quarter of 2024. Non-GAAP net loss for the first quarter of 2025 was $44.4 million, compared to ...
Thu, 08 May 2025 13:24:00 GMT The company also appointed a new CFO, Jim Gibson, to strengthen its financial leadership. Record consumables revenue achieved, indicating strong ongoing demand for PacBio's products. Initiated a ...
Thu, 08 May 2025 06:15:00 GMT Appointed Jim Gibson as Chief Financial Officer ... GAAP and non‐GAAP financial measures included in this press release. PacBio excludes recurring charges from its non-GAAP financial statements ...
Fri, 04 Apr 2025 18:45:00 GMT Jim Gibson, under the Pacific Biosciences 2020 Inducement Equity Incentive Plan (the “2020 Inducement Plan”), effective on March 31, 2025. The award was granted as an inducement material to ...
